A Year's Struggle: How Japan Is Recovering Damaged Generic Supplies After Quality Violations
Group Points To Pricing Risks
Japan struggles to recover its ever-expanding supply chain for generic drugs after several key players had their production stopped because of a series of GMP violations. As the share of generics grows under government policy, some in the industry argue the problems are deeply rooted in a decades-old pricing system.
